Decision Making and Future Planning for Children With Complex Illness
NCT ID: NCT02579577
Last Updated: 2017-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2015-10-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A multiple embedded case study utilising ethnographic methods (semi-structured interviews, observation and notes review) is proposed to address this knowledge gap. Families of children with LLI cared for in either of two participating hospitals will be recruited and followed up for up to 12 months. The family will be invited to nominate 'significant others' (e.g. relatives, friends, health care professionals) who assist them in decision making and future planning, to participate in the study. Outpatient clinic appointments or ward rounds during periods of hospitalisation will be observed and semi-structured interviews will be conducted approximately three times with each participant. Medical notes will be reviewed at the end of the study.
This research will enable a better understanding of the experiences and preferences for engaging in decision making and future planning from the perspectives of all stakeholders. It will also provide an awareness of the communication practices involved in discussions and the networks of care surrounding children with LLI, including specific support needs in relation to their role.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life of Children/Adolescents in Palliative Care Settings
NCT04527692
Developing a Symptom List for Children With Cancer
NCT02726815
Palliative Care and Symptom Management for the Pediatric Oncology Patient
NCT00675467
Uncertainty in Illness in Palliative Care: an Intervention for Family Caregivers
NCT03518970
Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease
NCT02175147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Decision making cohort
Any people identified as being important within the network of care for children with life-limiting illnesses.
Observation
Observation of clinic appointments and ward rounds if the child is admitted to hospital during the study period.
Interviews
Semi-structured interviews will be conducted approximately 3 times during the study period with each participant.
Medical notes review
The child's electronic medical record will be accessed periodically to identify any planned appointments or periods of hospitalisation and their medical notes will also be reviewed at the end of the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Observation of clinic appointments and ward rounds if the child is admitted to hospital during the study period.
Interviews
Semi-structured interviews will be conducted approximately 3 times during the study period with each participant.
Medical notes review
The child's electronic medical record will be accessed periodically to identify any planned appointments or periods of hospitalisation and their medical notes will also be reviewed at the end of the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Their child must have a LLI within categories 2-4 (Association for Children with Life-threatening and Terminal Conditions and their Families, 2004) (see page 8)
* Child must be under the care of a consultant at either of the two NHS Trusts included in the study
* The parent must be aware of the child's LLI diagnosis
* Participants must speak English. This is both due to resource constraints and due to the sensitive topic such that difficulties in translating questions sensitively may cause greater distress to participants.
* Children will be classed as participants if their parent is a participant and consents to their child's medical notes being accessed.
* For children to participate in the interview component of the study, they must be over the age of 7 years and cognitively able to provide their own assent (or consent, if over 16 years old)
* Parents must have agreed to the child's participation if they are under 16 years old
* Participants must speak English or be able to communicate in some way using alternative or augmentative communication.
* Significant others must have been identified by the eligible child and/or parents as being important in their decision making and future planning
* Participants must speak English
* Participants must be over the age of 7 years and provide their own assent alongside parental consent (if under 16 years old) or provide consent if they are over the age of 16 years (in the case of a friend or sibling being nominated as a 'significant other').
Exclusion Criteria
28 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bridget Johnston, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherwood Forest Hospitals NHS Trust
Mansfield, , United Kingdom
Nottingham University Hospitals NHS Trust
Nottingham, , United Kingdom
Sheffield Children's Hospital
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.